Equities

Safety Shot Inc

SHOT:NAQ

Safety Shot Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.24
  • Today's Change-0.22 / -15.07%
  • Shares traded1.03m
  • 1 Year change-18.95%
  • Beta1.8541
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Safety Shot Inc grew revenues 68.01% from 120.63k to 202.67k while net income improved from a loss of 15.22m to a smaller loss of 15.08m.
Gross margin-203.58%
Net profit margin-3,598.40%
Operating margin-3,198.78%
Return on assets-338.97%
Return on equity-608.07%
Return on investment-550.57%
More ▼

Cash flow in USDView more

In 2023, Safety Shot Inc increased its cash reserves by 159.44%, or 2.36m. Cash Flow from Financing totalled 12.80m or 6,315.50% of revenues. In addition the company used 10.11m for operations while cash used for investing totalled 330.05k.
Cash flow per share-0.8573
Price/Cash flow per share--
Book value per share0.1244
Tangible book value per share0.0416
More ▼

Balance sheet in USDView more

Safety Shot Inc has a Debt to Total Capital ratio of 26.09%.
Current ratio1.76
Quick ratio1.55
Total debt/total equity0.3529
Total debt/total capital0.2609
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.